SCHOTT Pharma recently announced an executive’s own transaction.
SCHOTT Pharma reported an insider deal to BaFin on December 18, 2025. SCHOTT Pharma reported the insider deal on December 18, 2025. Mayer, Reinhard, board member, acted optimistically with regard to the SCHOTT Pharma share certificate. A total of 2,999 shares were purchased on December 18, 2025 at EUR 14.93 each. The SCHOTT Pharma share was ultimately quoted at a discount of 0.30 percent at EUR 14.70 in FSE trading.
SCHOTT Pharma presented the paper at the FSE meeting on the day the news was published by BaFin. Ultimately it went down by percent to EUR. SCHOTT Pharma currently has a market capitalization of EUR 2.21 billion. There are currently 150,614,608 securities tradable on the stock exchange.
The previous insider trade with SCHOTT Pharma shares was recorded on March 1, 2024. Schulte, Dr. Jens, supervisory board member at SCHOTT Pharma, reduced his investment by 2,000 shares for EUR 40.00 each.
Editorial team finanzen.net
Selected leverage products on SCHOTT Pharma
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on SCHOTT Pharma
The leverage must be between 2 and 20
Advertising
